Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensign (ENSG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Ensign (ENSG) over the last 17 years, with Q4 2025 value amounting to $503.9 million.

  • Ensign's Cash & Equivalents rose 845.53% to $503.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $503.9 million, marking a year-over-year increase of 845.53%. This contributed to the annual value of $503.9 million for FY2025, which is 845.53% up from last year.
  • Ensign's Cash & Equivalents amounted to $503.9 million in Q4 2025, which was up 845.53% from $443.7 million recorded in Q3 2025.
  • Ensign's Cash & Equivalents' 5-year high stood at $532.1 million during Q3 2024, with a 5-year trough of $155.5 million in Q1 2021.
  • For the 5-year period, Ensign's Cash & Equivalents averaged around $369.2 million, with its median value being $345.5 million (2023).
  • Per our database at Business Quant, Ensign's Cash & Equivalents soared by 14602.08% in 2021 and then crashed by 4477.44% in 2025.
  • Over the past 5 years, Ensign's Cash & Equivalents (Quarter) stood at $262.2 million in 2021, then increased by 20.62% to $316.3 million in 2022, then skyrocketed by 61.14% to $509.6 million in 2023, then dropped by 8.84% to $464.6 million in 2024, then increased by 8.46% to $503.9 million in 2025.
  • Its Cash & Equivalents was $503.9 million in Q4 2025, compared to $443.7 million in Q3 2025 and $364.0 million in Q2 2025.